We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+15.21%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$436B
AUM Growth
+$83.7B
Cap. Flow
+$35.4B
Cap. Flow %
8.11%
Top 10 Hldgs %
42.78%
Holding
5,681
New
461
Increased
2,914
Reduced
1,346
Closed
463

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.6B
2
AVGO icon
Broadcom
AVGO
+$1.11B
3
QQQ icon
Invesco QQQ Trust
QQQ
+$882M
4
JPM icon
JPMorgan Chase
JPM
+$628M
5
TSLA icon
Tesla
TSLA
+$594M

Sector Composition

Rank Sector Weight
1 Technology 19.83%
2 Financials 7.37%
3 Consumer Discretionary 6.6%
4 Communication Services 5.05%
5 Healthcare 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCS icon
4926
Barclays
BCS
$94.3B
$428 ﹤0.01%
23
EWD icon
4927
iShares MSCI Sweden ETF
EWD
$593M
$412 ﹤0.01%
9
HBIO icon
4928
Harvard Bioscience
HBIO
$28.8M
$395 ﹤0.01%
89
-4,087
-98% -$17.1K
USL icon
4929
United States 12 Month Oil Fund,
USL
$45.6M
$386 ﹤0.01%
11
UNCY icon
4930
Unicycive Therapeutics
UNCY
$138M
$382 ﹤0.01%
+80
New +$495
ASPSW
4931
Altisource Portfolio Solutions SA Net Settle Stakeholder Warrants
ASPSW
$13.4M
$343 ﹤0.01%
+686
New +$322
DMRA
4932
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.82B
$341 ﹤0.01%
100
-33
-25% -$98
CPHC icon
4933
Canterbury Park Holding Corp
CPHC
$79.6M
$320 ﹤0.01%
+17
New +$301
JUNW icon
4934
AllianzIM U.S. Equity Buffer20 Jun ETF
JUNW
$374M
$319 ﹤0.01%
10
-1,619
-99% -$49.1K
GBLI icon
4935
Global Indemnity Group
GBLI
$423M
$282 ﹤0.01%
9
XELAP
4936
DELISTED
Exela Technologies, Inc. 6.00% Series B Cumulative Convertible Perpetual Preferred Stock
XELAP
$274 ﹤0.01%
24,900
TGE.WS
4937
The Generation Essentials Group Warrants
TGE.WS
$274 ﹤0.01%
+686
New +$366
PDYNW icon
4938
Palladyne AI Corp Warrants
PDYNW
$169K
$190 ﹤0.01%
500
RAPT
4939
DELISTED
RAPT Therapeutics
RAPT
$176 ﹤0.01%
22
-4,350
-99% -$33.2K
INO icon
4940
Inovio Pharmaceuticals
INO
$76.1M
$167 ﹤0.01%
82
-36,327
-100% -$69.6K
OTLK icon
4941
Outlook Therapeutics
OTLK
$215M
$162 ﹤0.01%
101
-16,939
-99% -$27K
ONDS icon
4942
Ondas Inc
ONDS
$5.31B
$134 ﹤0.01%
+70
New +$78
BBU
4943
DELISTED
Brookfield Business Partners
BBU
$130 ﹤0.01%
5
-52
-91% -$1.22K
EMPD
4944
Empery Digital
EMPD
$70.8M
$125 ﹤0.01%
18
-1
-5% -$6
ASPSZ
4945
Altisource Portfolio Solutions SA Cash Exercise Stakeholder Warrants
ASPSZ
$7.4M
$124 ﹤0.01%
+244
New +$126
SONM icon
4946
DNA X Inc
SONM
$5.24M
$122 ﹤0.01%
+6
New +$148
MAIN icon
4947
Main Street Capital
MAIN
$5.44B
$118 ﹤0.01%
2
-59,283
-100% -$3.28M
PSTP icon
4948
Innovator Power Buffer Step-Up Strategy ETF
PSTP
$133M
$100 ﹤0.01%
3
-125
-98% -$3.98K
BW icon
4949
Babcock & Wilcox
BW
$1.32B
$97 ﹤0.01%
101
-54,723
-100% -$37.4K
GCTS
4950
GCT Semiconductor Holding
GCTS
$225M
$95 ﹤0.01%
64
-8,435
-99% -$11.4K

Similar funds

Barclays's Q2 2025 Portfolio in Review

As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.

  • Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
  • Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
  • Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
  • Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
  • Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
  • Barclays opened 461 new positions and closed 463 in Q2 2025.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $436B.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.